Status:
COMPLETED
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
Lead Sponsor:
University of Zurich
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Environmental factors may play a role in the genesis of pulmonary hypertension, especially in endothelial dysfunction. One widespread environmental factor associated with systemic endothelial dysfunct...
Eligibility Criteria
Inclusion
- pulmonary artery pressure \>25mmHg
- pulmonary capillary occlusion pressure ≤15mmHg
Exclusion
- pulmonary artery pressure \<25mmHg
- pulmonary capillary occlusion pressure \>15mmHg
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01484899
Start Date
September 1 2011
End Date
December 1 2012
Last Update
July 8 2013
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Graz
Graz, Austria
2
University Hospital of Innsbruck
Innsbruck, Austria
3
University Hospital Dresden
Dresden, Germany
4
University of Greifswald
Greifswald, Germany